Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 3546 entries
View as:

Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT00043927 Org: User:
Start: 04/30/01 End: - Due: -

A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study

Phase: N/A Priority: Normal
NCT ID: NCT00307554 Org: User:
Start: 11/30/05 End: 06/30/06 Due: 06/30/07

Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy

Phase: N/A Priority: Normal
NCT ID: NCT01772160 Org: User:
Start: 02/26/13 End: 10/05/16 Due: 10/05/17

Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01702337 Org: User:
Start: 02/28/10 End: 02/28/10 Due: 02/28/11

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Phase: N/A Priority: Normal
NCT ID: NCT00920140 Org: User:
Start: 05/31/11 End: 04/30/13 Due: 04/30/14

Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03031496 Org: User:
Start: 03/17/17 End: 04/10/17 Due: 04/10/18

Drug Use Investigation for FLOLAN (Epoprostenol) Injection 0.5mg・1.5mg

Phase: N/A Priority: Normal
NCT ID: NCT01387191 Org: User:
Start: 08/31/99 End: 07/31/09 Due: 07/31/10

Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00101946 Org: User:
Start: 10/31/04 End: 07/31/06 Due: 07/31/07

Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB

Phase: N/A Priority: Normal
NCT ID: NCT00359983 Org: User:
Start: 09/30/06 End: 05/31/11 Due: 05/31/12

Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03150056 Org: User:
Start: 07/18/17 End: 06/22/21 Due: 06/22/22

Avandamet Bioequivalence Study Brazil - Fed Administration

Phase: N/A Priority: Normal
NCT ID: NCT01332071 Org: User:
Start: 11/24/09 End: 12/06/09 Due: 12/06/10

Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT01808313 Org: User:
Start: 12/01/12 End: 08/15/14 Due: 08/15/15

Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.

Phase: N/A Priority: Normal
NCT ID: NCT00394056 Org: User:
Start: 12/31/06 End: 08/31/09 Due: 08/31/10

Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01431924 Org: User:
Start: 10/31/10 End: 01/31/12 Due: 01/31/13

A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa

Phase: N/A Priority: Normal
NCT ID: NCT00263666 Org: User:
Start: 03/16/05 End: 02/13/08 Due: 02/13/09

Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)

Phase: N/A Priority: Normal
NCT ID: NCT01376128 Org: User:
Start: 03/31/08 End: 05/31/09 Due: 05/31/10

Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype

Phase: N/A Priority: Normal
NCT ID: NCT00697749 Org: User:
Start: 04/30/99 End: 01/31/00 Due: 01/31/01

Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate

Phase: N/A Priority: Normal
NCT ID: NCT00374842 Org: User:
Start: 10/03/06 End: 11/30/06 Due: 11/30/07

Pharmacokinetic Study of 4 mg Nicotine Lozenge.

Phase: N/A Priority: Normal
NCT ID: NCT01669122 Org: User:
Start: 06/30/12 End: 08/31/12 Due: 08/31/13

Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT01227902 Org: User:
Start: 07/31/10 End: 12/31/12 Due: 12/31/13

A Non-investigational Product (IP) Study to Investigate Lung Function in Women in the Third Stage of Labour

Phase: N/A Priority: Normal
NCT ID: NCT02106000 Org: User:
Start: 06/24/14 End: 12/20/14 Due: 12/20/15

Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)

Phase: N/A Priority: Normal
NCT ID: NCT01300234 Org: User:
Start: 03/30/11 End: 12/06/16 Due: 12/06/17

Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01957163 Org: User:
Start: 10/01/13 End: 04/01/14 Due: 04/01/15

24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01316913 Org: User:
Start: 03/31/11 End: 04/30/12 Due: 04/30/13

Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years

Phase: N/A Priority: Normal
NCT ID: NCT00718120 Org: User:
Start: 07/18/08 End: 08/09/08 Due: 08/09/09